Oakmont Partners »

Corcept Therapeutics Incorporated shares owned by Oakmont Partners

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Oakmont Partners from 13F filings

Historical chart of Oakmont Partners investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Oakmont Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Oakmont Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $981k 30k 32.48
2023-09-30 $823k 30k 27.25
2023-06-30 $672k 30k 22.25
2023-03-31 $654k 30k 21.66
2022-12-31 $613k 30k 20.31
2022-09-30 $774k 30k 25.63

More positions owned by Oakmont Partners

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Pfd And Incm Sec (PFF)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Tips Bd Etf (TIP)
Costco Wholesale Corporation (COST)
Meta Platforms Cl A (META)
Ishares Tr S&p 100 Etf (OEF)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Oakmont Partners

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated